IDEXX Laboratories Inc (IDXX) stock
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)
Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –
IDEXX Laboratories EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
IDEXX Laboratories's EV/EBITDA was 34.5× on Nov 11, 2026, against 41.9× a year earlier. Over the last 5 years it ranged from 25.7× to 55.5×, with a median of 34.1×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 34.5× | −3.1 |
| 2025 | Dec 31, 2025 | 37.6× | +10.0 |
| 2024 | Dec 31, 2024 | 27.7× | −11.4 |
| 2023 | Dec 29, 2023 | 39.0× | +3.9 |
| 2022 | Dec 30, 2022 | 35.1× | −20.4 |
| 2021 | Dec 31, 2021 | 55.5× | −4.8 |
| 2020 | Dec 31, 2020 | 60.3× | +25.3 |
| 2019 | Dec 31, 2019 | 35.0× | +6.4 |
| 2018 | Dec 31, 2018 | 28.6× | +0.3 |
| 2017 | Dec 29, 2017 | 28.3× | +3.1 |
| 2016 | Dec 30, 2016 | 25.2× | +6.3 |
| 2015 | Dec 31, 2015 | 18.8× | −2.6 |
| 2014 | Dec 31, 2014 | 21.5× | +4.3 |
| 2013 | Dec 31, 2013 | 17.2× | +0.8 |
| 2012 | Dec 31, 2012 | 16.4× | +0.8 |
| 2011 | Dec 30, 2011 | 15.6× | −0.9 |
| 2010 | Dec 31, 2010 | 16.4× | +1.7 |
| 2009 | Dec 31, 2009 | 14.7× | – |
See a number that looks wrong?